Concepedia

Pharmacokinetics, Safety, and Tolerability of a 2-Month Dose Interval Regimen of the Long-Acting Injectable Antipsychotic Aripiprazole Lauroxil: Results From a 44-Week Phase I Study

Peter J. Weiden, Yangchun Du, Lisa Von Moltke, Angela Wehr, Marjie Hard, Morteza Marandi, David P. Walling

CNS Drugs · 2020 · 16 citations · 16 references

DOIFull text

Open access

References

16

Efficacy and Safety of Aripiprazole and Haloperidol Versus Placebo in Patients With Schizophrenia and Schizoaffective Disorder

John M. Kane, William H. Carson, Anutosh Ranjan Saha et al. · The Journal of Clinical Psychiatry · 2002 · 622 citations

Manual for the Extrapyramidal Symptom Rating Scale (ESRS)

Guy Chouinard, Howard C. Margolese · Schizophrenia Research · 2005 · 408 citations

, , +2

Drug Interaction: Inhibitory Effect of Neuroleptics on Metabolism of Tricyclic Antidepressants in Man

L. F. Gram, K. Fredricson Overø · BMJ · 1972 · 177 citations · Full text

, , +21

Treatment strategies to prevent relapse and encourage remission.

John M. Kane · PubMed · 2007 · 128 citations

, , +19

A Randomized, Double-Blind, Placebo-Controlled Trial of Aripiprazole Lauroxil in Acute Exacerbation of Schizophrenia

Herbert Y. Meltzer, Robert Risinger, Henry A. Nasrallah et al. · The Journal of Clinical Psychiatry · 2015 · 113 citations · Full text